Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve Stenosis | 6 | 2025 | 166 | 1.470 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2024 | 197 | 1.380 |
Why?
|
| Transcatheter Aortic Valve Replacement | 4 | 2025 | 72 | 1.110 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2023 | 76 | 1.010 |
Why?
|
| Balloon Valvuloplasty | 3 | 2020 | 8 | 0.850 |
Why?
|
| Cardiac Catheterization | 5 | 2024 | 330 | 0.830 |
Why?
|
| Drug-Eluting Stents | 4 | 2016 | 22 | 0.750 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2024 | 209 | 0.730 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2010 | 67 | 0.660 |
Why?
|
| Coronary Artery Disease | 4 | 2025 | 394 | 0.620 |
Why?
|
| Coronary Vessels | 3 | 2025 | 201 | 0.550 |
Why?
|
| Angioplasty | 2 | 2014 | 69 | 0.500 |
Why?
|
| Stents | 2 | 2008 | 422 | 0.420 |
Why?
|
| Atrial Flutter | 1 | 2014 | 37 | 0.420 |
Why?
|
| Septal Occluder Device | 1 | 2014 | 56 | 0.410 |
Why?
|
| Atrial Appendage | 1 | 2014 | 39 | 0.410 |
Why?
|
| Aorta, Abdominal | 1 | 2013 | 60 | 0.410 |
Why?
|
| Coronary Angiography | 4 | 2025 | 261 | 0.390 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2013 | 111 | 0.390 |
Why?
|
| Aortic Diseases | 1 | 2013 | 104 | 0.380 |
Why?
|
| Heart Valve Prosthesis | 4 | 2024 | 106 | 0.380 |
Why?
|
| Treatment Outcome | 16 | 2025 | 9175 | 0.370 |
Why?
|
| Heart Atria | 1 | 2014 | 290 | 0.370 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2022 | 143 | 0.350 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2023 | 514 | 0.330 |
Why?
|
| Prosthesis Failure | 2 | 2024 | 125 | 0.330 |
Why?
|
| Coronary Restenosis | 1 | 2010 | 12 | 0.320 |
Why?
|
| Prosthesis Design | 4 | 2024 | 310 | 0.320 |
Why?
|
| Paclitaxel | 2 | 2016 | 497 | 0.310 |
Why?
|
| Sirolimus | 1 | 2010 | 177 | 0.290 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2022 | 180 | 0.290 |
Why?
|
| Coronary Aneurysm | 1 | 2008 | 16 | 0.290 |
Why?
|
| Mitral Valve | 5 | 2024 | 279 | 0.270 |
Why?
|
| Embolism | 1 | 2006 | 34 | 0.240 |
Why?
|
| Chest Pain | 1 | 2006 | 48 | 0.230 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2025 | 5 | 0.230 |
Why?
|
| Computed Tomography Angiography | 2 | 2025 | 166 | 0.230 |
Why?
|
| Multidetector Computed Tomography | 1 | 2025 | 61 | 0.220 |
Why?
|
| Bioprosthesis | 1 | 2024 | 43 | 0.210 |
Why?
|
| Femoral Artery | 2 | 2017 | 91 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2022 | 9 | 0.190 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2022 | 10 | 0.190 |
Why?
|
| Male | 16 | 2025 | 45865 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1981 | 0.190 |
Why?
|
| Aged | 12 | 2025 | 20968 | 0.190 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2016 | 276 | 0.180 |
Why?
|
| Aortic Valve | 2 | 2022 | 273 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 281 | 0.180 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2020 | 15 | 0.170 |
Why?
|
| Humans | 24 | 2025 | 96109 | 0.170 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 429 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 132 | 0.150 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 7229 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 258 | 0.150 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2017 | 362 | 0.140 |
Why?
|
| Cutaneous Fistula | 1 | 2017 | 10 | 0.130 |
Why?
|
| Vascular Fistula | 1 | 2017 | 12 | 0.130 |
Why?
|
| Hemostasis, Surgical | 1 | 2017 | 25 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 50 | 0.130 |
Why?
|
| Hemostatics | 1 | 2017 | 61 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 64 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 2 | 2008 | 125 | 0.130 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2016 | 2 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 771 | 0.120 |
Why?
|
| Angiography | 2 | 2014 | 209 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2017 | 121 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 1805 | 0.120 |
Why?
|
| Radiography, Interventional | 2 | 2013 | 154 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2016 | 100 | 0.120 |
Why?
|
| Angioplasty, Balloon | 1 | 2016 | 98 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 96 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2017 | 188 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2025 | 4671 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2013 | 138 | 0.110 |
Why?
|
| Ligation | 1 | 2014 | 53 | 0.110 |
Why?
|
| Cardiac Catheters | 1 | 2013 | 14 | 0.100 |
Why?
|
| Surgical Instruments | 1 | 2014 | 63 | 0.100 |
Why?
|
| Aortography | 1 | 2013 | 67 | 0.100 |
Why?
|
| Time Factors | 4 | 2025 | 5580 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2016 | 266 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2013 | 110 | 0.090 |
Why?
|
| Punctures | 1 | 2011 | 29 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 392 | 0.090 |
Why?
|
| Retreatment | 1 | 2010 | 106 | 0.080 |
Why?
|
| Middle Aged | 5 | 2024 | 28369 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 3927 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2024 | 2480 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2010 | 237 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2024 | 348 | 0.080 |
Why?
|
| Risk Factors | 3 | 2024 | 5961 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 16 | 0.070 |
Why?
|
| Platelet Aggregation | 1 | 2008 | 45 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 26 | 0.070 |
Why?
|
| Metals | 1 | 2008 | 102 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 39 | 0.070 |
Why?
|
| Hospitalization | 2 | 2023 | 943 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 1196 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2777 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2010 | 1546 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2020 | 10287 | 0.060 |
Why?
|
| Female | 7 | 2025 | 50031 | 0.060 |
Why?
|
| Mitral Valve Stenosis | 1 | 2024 | 38 | 0.050 |
Why?
|
| Canada | 1 | 2023 | 215 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1219 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2006 | 983 | 0.050 |
Why?
|
| Pharmacogenomic Variants | 1 | 2022 | 44 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 169 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2022 | 107 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 938 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 294 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2024 | 775 | 0.040 |
Why?
|
| Prognosis | 2 | 2023 | 4029 | 0.040 |
Why?
|
| Genotype | 1 | 2022 | 1881 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1137 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 83 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 107 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 114 | 0.030 |
Why?
|
| Stroke | 1 | 2024 | 1087 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 296 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 707 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 709 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2013 | 48 | 0.020 |
Why?
|
| Arterial Pressure | 1 | 2013 | 42 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 427 | 0.020 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2017 | 528 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 1816 | 0.020 |
Why?
|
| Aorta | 1 | 2013 | 294 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7768 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 340 | 0.020 |
Why?
|
| Heart Rate | 1 | 2013 | 518 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 522 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 143 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 662 | 0.020 |
Why?
|
| Contrast Media | 1 | 2013 | 1096 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2011 | 314 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 60 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2008 | 156 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 1422 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 28722 | 0.010 |
Why?
|